We are live on ! Find out more
VWM

Vigilare Wealth Management Portfolio holdings

AUM $326M
1-Year Est. Return 21.58%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+21.58%
3 Year Est. Return
+56.88%
5 Year Est. Return
+49.16%
10 Year Est. Return
AUM
$96M
AUM Growth
-$2.54M
Cap. Flow
-$10.3M
Cap. Flow %
-10.69%
Top 10 Hldgs %
33.95%
Holding
147
New
24
Increased
35
Reduced
64
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Healthcare 11.71%
3 Communication Services 9.25%
4 Consumer Discretionary 8.87%
5 Consumer Staples 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUPH icon
126
Aurinia Pharmaceuticals
AUPH
$2.11B
$187K 0.19%
12,720
+120
+1% +$1.74K
OCUL icon
127
Ocular Therapeutix
OCUL
$2.02B
$139K 0.14%
18,200
+900
+5% +$7.47K
DMTK
128
DELISTED
DermTech, Inc. Common Stock
DMTK
$131K 0.14%
+11,000
New +$127K
AFMD
129
DELISTED
Affimed
AFMD
$128K 0.13%
3,780
+851
+29% +$32.2K
USA icon
130
Liberty All-Star Equity Fund
USA
$1.85B
$121K 0.13%
20,200
ATNX
131
DELISTED
Athenex, Inc. Common Stock
ATNX
$121K 0.13%
+500
New +$120K
UROV
132
DELISTED
Urovant Sciences Ltd.
UROV
$121K 0.13%
13,000
+2,800
+27% +$24.9K
AMRN
133
Amarin Corp
AMRN
$303M
$96K 0.1%
1,139
-125
-10% -$15K
APTO
134
DELISTED
Aptose Biosciences, Inc.
APTO
$90K 0.09%
+33
New +$82.3K
TCON
135
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$88K 0.09%
+850
New +$45.5K
BCRX icon
136
BioCryst Pharmaceuticals
BCRX
$2.4B
$50K 0.05%
+14,500
New +$62.1K
GMDA
137
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$50K 0.05%
+12,000
New +$51.1K
NOK icon
138
Nokia
NOK
$52.3B
$47K 0.05%
12,000
CSCO icon
139
Cisco
CSCO
$479B
-4,691
Closed -$219K
EXC icon
140
Exelon
EXC
$47B
-9,190
Closed -$238K
INTC icon
141
PUT
Intel
INTC
$513B
-13,500
Closed -$807K
SDS icon
142
CALL
ProShares UltraShort S&P500
SDS
$390M
-40
Closed -$19K
SH icon
143
CALL
ProShares Short S&P500
SH
$897M
-1,375
Closed -$123K
SPY icon
144
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
-22,500
Closed -$6.94M
SRPT icon
145
Sarepta Therapeutics
SRPT
$1.77B
-1,265
Closed -$203K
VSTM icon
146
Verastem
VSTM
$610M
-917
Closed -$19K
GWPH
147
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-2,035
Closed -$250K

Similar funds

Vigilare Wealth Management's Q3 2020 Portfolio in Review

As of Q3 2020, Vigilare Wealth Management held 147 positions worth $96M, down 2.6% from $98.5M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Vigilare Wealth Management withdrew a net $10.3M in Q3 2020, closing 9 positions and reducing 64 holdings. Its most notable exit was GW Pharmaceuticals Plc American Depositary Shares, an estimated $250K position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Vigilare Wealth Management opened a new position in Goldman Sachs Physical Gold ETF Shares worth $686K.

  • Vigilare Wealth Management's largest Q3 2020 buy was Goldman Sachs Physical Gold ETF Shares: 36,500 shares worth $686K.
  • Vigilare Wealth Management added most to JPMorgan Ultra-Short Income ETF in Q3 2020, an estimated $318K increase.
  • Vigilare Wealth Management's biggest Q3 2020 reduction was Apple, cutting an estimated $936K.
  • Vigilare Wealth Management fully exited GW Pharmaceuticals Plc American Depositary Shares in Q3 2020, selling an estimated $250K.
  • Vigilare Wealth Management's ten largest holdings make up 34% of its $96M portfolio in Q3 2020.
  • Vigilare Wealth Management opened 24 new positions and closed 9 in Q3 2020.
  • Vigilare Wealth Management's portfolio value fell 2.6% quarter-over-quarter to $96M.

Based on Vigilare Wealth Management's 13F filing for Q3 2020, filed 15 Oct 2020.